Protheos
Protheos, a leading player in the biotechnology sector, is headquartered in France and operates extensively across Europe. Founded in 2015, the company has rapidly established itself as a pioneer in the development of innovative biopharmaceutical solutions, focusing on advanced therapies and personalised medicine. Protheos is renowned for its unique approach to drug development, leveraging cutting-edge technologies to enhance therapeutic efficacy and patient outcomes. With a commitment to research and development, the company has achieved significant milestones, including collaborations with major pharmaceutical firms and successful clinical trials. As a trusted name in the industry, Protheos continues to push the boundaries of biotechnology, positioning itself at the forefront of medical advancements and contributing to the evolution of healthcare solutions.
DitchCarbon Score
How does Protheos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Protheos's score of 26 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Protheos's reported carbon emissions
Protheos, headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available at this time. This lack of data suggests that Protheos may still be in the early stages of establishing its climate commitments or may not have publicly disclosed its emissions profile. As the company moves forward, it may consider aligning with industry standards and frameworks such as the Science Based Targets initiative (SBTi) to set measurable and ambitious climate goals. Engaging in such initiatives could enhance Protheos's commitment to sustainability and carbon reduction, positioning it favourably within the industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Protheos is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
